Kenneth Wen

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma”.

Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma

Leukemia(2021)10.1038/s41375-021-01301-6

N/A

2.1DataRank · unranked

76 citations

Fabrizio Accardi, Teru Hideshima, Yu‐Tzu Tai, Rao Prabhala, Aaron Shambley +6 more

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Nature Communications(2024)10.1038/s41467-024-45561-z

N/A

1.0DataRank · unranked

35 citations

Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu +17 more

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Blood Cancer Journal(2022)10.1038/s41408-022-00716-3

N/A

0.604DataRank · unranked

55 citations

Tengteng Yu, Liang Lin, Lijie Xing, Shih‐Feng Cho, Kenneth Wen +9 more

BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3668

N/A

0.529DataRank · unranked

33 citations

Mehmet Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu +7 more

Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01834

N/A

0.500DataRank · unranked

27 citations

Yao Liu, Yang Gao, Qixiang Geng, Deepak Gurbani, Lianbo Li +17 more

Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

Blood(2024)10.1182/blood.2023022777

N/A

0.457DataRank · unranked

20 citations

Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet Samur, Cirino Botta +24 more

Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Leukemia(2022)10.1038/s41375-022-01588-z

N/A

0DataRank · unranked

0 citations

Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey Fell, Yu‐Tzu Tai +7 more

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

Science Advances(2021)10.1126/sciadv.abg2697

N/A

0DataRank · unranked

26 citations

Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Samur +15 more

BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma

Blood Cancer Journal(2023)10.1038/s41408-023-00955-y

N/A

0DataRank · unranked

23 citations

Jiye Liu, Kenneth Wen, Keiji Kurata, Mariateresa Fulciniti, Annamaria Gullà +3 more

Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0047

N/A

0DataRank · unranked

139 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

(2023)10.1158/1078-0432.c.6530600.v1

N/A

0DataRank · unranked

0 citations

Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen +11 more

Data from Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

(2023)10.1158/2643-3230.c.6550306

N/A

0DataRank · unranked

0 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma

Blood(2020)10.1182/blood.2019004147

N/A

0DataRank · unranked

27 citations

Mariateresa Fulciniti, Mehmet Samur, Matthew Ho, Shuhui Deng, Lanting Liu +20 more

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Blood Cancer Journal(2020)10.1038/s41408-020-00378-z

N/A

0DataRank · unranked

44 citations

Bharat K. R. Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen +18 more